Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Laparoscopic Versus Open Pancreaticoduodenectomy For Ampullary Cancer: A Retrospective Study.
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Laparoscopic Versus Open Pancreaticoduodenectomy For Ampullary Cancer: A Retrospective Study.

Related Experiment Video

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy
08:57

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy

Published on: June 17, 2018

15.0K

Laparoscopic versus open pancreaticoduodenectomy for ampullary cancer: A retrospective study.

Masayoshi Sakuma1, Atsuyuki Maeda1, Yuichi Takayama1

  • 1Department of Surgery, Ogaki Municipal Hospital, Gifu, Japan.

Asian Journal of Endoscopic Surgery
|July 10, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Laparoscopic pancreaticoduodenectomy (LPD) offers outcomes comparable to open pancreaticoduodenectomy (OPD) for ampullary carcinoma (AC). LPD is a viable standard treatment due to reduced blood loss and shorter hospital stays.

Keywords:
ampullary cancerlaparoscopic surgerypancreaticoduodenectomy

More Related Videos

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.0K
Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

9.5K

Related Experiment Videos

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy
08:57

Laparoscopic Pancreatoduodenectomy With Modified Blumgart Pancreaticojejunostomy

Published on: June 17, 2018

15.0K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.0K
Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
10:04

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video

Published on: June 6, 2020

9.5K

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Minimally Invasive Surgery

Background:

  • Limited comparative studies exist for laparoscopic pancreaticoduodenectomy (LPD) versus open pancreaticoduodenectomy (OPD) in ampullary carcinoma (AC).
  • Evaluating short- and long-term outcomes is crucial for treatment selection.

Purpose of the Study:

  • To compare short- and long-term outcomes of LPD and OPD for ampullary carcinoma.
  • To assess the efficacy and safety of LPD as a potential standard treatment for AC.

Main Methods:

  • Retrospective analysis of 55 patients with AC undergoing pancreaticoduodenectomy (PD) with curative intent.
  • Comparison of outcomes between LPD (n=26) and OPD (n=29) groups.

Main Results:

  • LPD showed significantly longer operative time, but less blood loss and shorter hospital stay compared to OPD.
  • No significant differences in morbidity, lymph node metastasis, pathological stages, overall survival (OS), or recurrence-free survival (RFS).
  • 3- and 5-year OS rates were comparable: LPD (63.0%/54%) vs. OPD (64.8%/61.2%).
  • Conclusions:

    • LPD demonstrates comparable short- and long-term oncological outcomes to OPD for ampullary carcinoma.
    • LPD is a safe and effective alternative, recommended for its benefits of reduced blood loss and shorter hospital stay.